SOX12 overexpression was significantly associated with tumor invasion, tumor differentiation, lymph node metastasis, distant metastasis, and American Joint Committee on Cancer (AJCC) staging (Supplementary Table S1), and was found to be an independent risk factor for reduced survival and recurrence in patients (Supplementary Table S2). The gene discussed is SOX12; the disease is neoplasm.